ResMed (NYSE:RMD) Third Quarter 2024 Results Key Financial Results Revenue: US$1.20b (up 7.2% from 3Q 2023). Net income: US$300.5m (up 29% from 3Q 2023). Profit margin: 25% (up from 21% in 3Q 2023). ...
Source LinkResMed (NYSE:RMD) Third Quarter 2024 Results Key Financial Results Revenue: US$1.20b (up 7.2% from 3Q 2023). Net income: US$300.5m (up 29% from 3Q 2023). Profit margin: 25% (up from 21% in 3Q 2023). ...
Source Link
Comments